GLPwatch

Brainstem BDNF neurons are downstream of GFRAL/GLP1R signalling.

Nat Commun · 2024

Last updated 2026-05-28

In mice, a specific brain pathway involving BDNF neurons in the brainstem is linked to the weight-loss effects of GLP-1 drugs like Exendin-4 and the hormone GDF15. These neurons are activated by signals from brainstem cells that respond to both GLP-1 and GDF15. Activating these BDNF neurons alone was enough to reduce food intake and increase fat burning in the short term.

AI summary of the abstract below.

JournalNat Commun, 2024
Citations9
Relative citation ratio1.55
NIH percentile66
Molecules

Abstract

Growth differentiation factor 15, GDF15, and glucagon-like peptide-1 (GLP-1) analogues act through brainstem neurons that co-localise their receptors, GDNF-family receptor α-like (GFRAL) and GLP1R, to reduce food intake and body weight. However, their use as clinical treatments is partially hampered since both can also induce sickness-like behaviours, including aversion, that are mediated through a well-characterised pathway via the exterolateral parabrachial nucleus. Here, in mice, we describe a separate pathway downstream of GFRAL/GLP1R neurons that involves a distinct population of brain-derived neurotrophic factor (BDNF) cells in the medial nucleus of the tractus solitarius. Thus, BDNF neurons are required for the weight-reducing actions of both GDF15 and the GLP1RA, Exendin-4. Moreover, acute activation of BDNF neurons is sufficient to reduce food intake and drive fatty acid oxidation and might provide a route for longer-term weight loss.

Verbatim abstract via PubMed 39737892 ↗